BR112015001847A2 - composições e tratamento para doenças e distúrbios nos olhos - Google Patents
composições e tratamento para doenças e distúrbios nos olhos Download PDFInfo
- Publication number
- BR112015001847A2 BR112015001847A2 BR112015001847A BR112015001847A BR112015001847A2 BR 112015001847 A2 BR112015001847 A2 BR 112015001847A2 BR 112015001847 A BR112015001847 A BR 112015001847A BR 112015001847 A BR112015001847 A BR 112015001847A BR 112015001847 A2 BR112015001847 A2 BR 112015001847A2
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- disorders
- eye diseases
- treatment
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Abstract
abstract: (en)the invention relates to compositions and methods for treating eye diseases and disorders. more specifically, the invention provides compositions comprising progesterone and methods of treating ocular surface diseases and disorders comprising applying such compositions topically. tradução do resumo resumo patente de invenção: "composições e tratamento para doenças e distúrbios nos olhos". a presente invenção refere-se a composições e métodos para tratamento de doenças e distúrbios dos olhos. mais especificamente, a presente invenção provê composições compreendendo progesterona e métodos para tratamento doenças e distúrbios da superfície ocular compreendendo aplicar topicamente tais composições. 1/1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261676530P | 2012-07-27 | 2012-07-27 | |
| US201361756321P | 2013-01-24 | 2013-01-24 | |
| PCT/US2013/052264 WO2014018856A1 (en) | 2012-07-27 | 2013-07-26 | Compositions and treatment for eye diseases and disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112015001847A2 true BR112015001847A2 (pt) | 2017-07-04 |
| BR112015001847A8 BR112015001847A8 (pt) | 2021-09-08 |
Family
ID=49997851
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015001847A BR112015001847A8 (pt) | 2012-07-27 | 2013-07-26 | Composições e tratamento para doenças e distúrbios nos olhos |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US20150216877A1 (pt) |
| EP (1) | EP2877184B1 (pt) |
| JP (1) | JP6209777B2 (pt) |
| KR (1) | KR102097663B1 (pt) |
| CN (2) | CN104661663A (pt) |
| AU (1) | AU2013295645B2 (pt) |
| BR (1) | BR112015001847A8 (pt) |
| CA (1) | CA2880027C (pt) |
| DK (1) | DK2877184T3 (pt) |
| ES (1) | ES2759781T3 (pt) |
| HK (1) | HK1210968A1 (pt) |
| HU (1) | HUE046963T2 (pt) |
| IL (1) | IL236920B (pt) |
| IN (1) | IN2015DN00542A (pt) |
| MX (1) | MX362185B (pt) |
| NZ (1) | NZ704247A (pt) |
| PL (1) | PL2877184T3 (pt) |
| PT (1) | PT2877184T (pt) |
| WO (1) | WO2014018856A1 (pt) |
| ZA (1) | ZA201500561B (pt) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| ES2885523T3 (es) | 2011-11-23 | 2021-12-14 | Therapeuticsmd Inc | Formulaciones y terapias de reposición hormonal de combinación naturales |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| MX2015013186A (es) | 2013-03-15 | 2016-04-15 | Glia Llc | Adminitracion craneal de productos farmaceuticos. |
| WO2015080758A1 (en) * | 2013-11-27 | 2015-06-04 | Al-Qahtani Ahmed H | Method and composition for the treatment of moderate to severe keratoconjunctivitis sicca |
| RU2016143081A (ru) | 2014-05-22 | 2018-06-26 | Терапьютиксмд, Инк. | Натуральные комбинированные гормонозаместительные составы и терапии |
| WO2016014419A1 (en) | 2014-07-21 | 2016-01-28 | Glia, Llc | Method for treating radiotherapy-and-chemotherapy associated cognitive or emotional impairment with cannabinoids |
| JP2017523138A (ja) | 2014-07-29 | 2017-08-17 | セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． | 経皮クリーム |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| US9931349B2 (en) | 2016-04-01 | 2018-04-03 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
| KR101960023B1 (ko) * | 2016-12-21 | 2019-03-20 | 김보경 | 이산화탄소 발생 장치 |
| WO2021163253A1 (en) * | 2020-02-12 | 2021-08-19 | Glia, Llc | Progesterone combinations |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5102656A (en) | 1983-07-29 | 1992-04-07 | The Mennen Company | Antiperspirant creams |
| US4937069A (en) | 1985-11-15 | 1990-06-26 | Bristol-Myers Squibb Company | Anhydrous semi-solid antiperspirant suspension |
| US5069897A (en) | 1987-10-16 | 1991-12-03 | The Proctor & Gamble Company | Antiperspirant creams |
| US6659985B2 (en) | 2002-01-30 | 2003-12-09 | Southern College Of Optometry | Method to use transdermal administration of androgens to the adnexa of the eye |
| US7572780B2 (en) | 2003-01-21 | 2009-08-11 | Dimera, Incorporated | Method and kit for reducing the symptoms of peripheral vascular disease |
| US20080132475A1 (en) | 2006-12-05 | 2008-06-05 | Charles Gerald Connor | Treatment for dry eye |
| AU2008309923B2 (en) | 2007-10-08 | 2014-04-03 | Fovea Pharmaceuticals | Aqueous ophthalmic formulations |
| US20100016264A1 (en) * | 2007-12-05 | 2010-01-21 | Connor Charles G | Treatment for dry eye using testosterone and progestagen |
| CN101757622A (zh) * | 2008-11-28 | 2010-06-30 | 天津金耀集团有限公司 | 一种眼部抗炎的药物组合物 |
| CA2776366C (en) * | 2009-10-02 | 2017-07-18 | Foamix Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
-
2013
- 2013-07-26 ES ES13823485T patent/ES2759781T3/es active Active
- 2013-07-26 BR BR112015001847A patent/BR112015001847A8/pt not_active Application Discontinuation
- 2013-07-26 AU AU2013295645A patent/AU2013295645B2/en active Active
- 2013-07-26 CN CN201380039713.2A patent/CN104661663A/zh active Pending
- 2013-07-26 MX MX2015001250A patent/MX362185B/es active IP Right Grant
- 2013-07-26 EP EP13823485.1A patent/EP2877184B1/en active Active
- 2013-07-26 PL PL13823485T patent/PL2877184T3/pl unknown
- 2013-07-26 JP JP2015524465A patent/JP6209777B2/ja active Active
- 2013-07-26 DK DK13823485T patent/DK2877184T3/da active
- 2013-07-26 CA CA2880027A patent/CA2880027C/en active Active
- 2013-07-26 US US14/417,640 patent/US20150216877A1/en not_active Abandoned
- 2013-07-26 WO PCT/US2013/052264 patent/WO2014018856A1/en active Application Filing
- 2013-07-26 CN CN201710063950.2A patent/CN107595857A/zh active Pending
- 2013-07-26 IN IN542DEN2015 patent/IN2015DN00542A/en unknown
- 2013-07-26 HU HUE13823485A patent/HUE046963T2/hu unknown
- 2013-07-26 KR KR1020157004782A patent/KR102097663B1/ko active IP Right Grant
- 2013-07-26 NZ NZ704247A patent/NZ704247A/en unknown
- 2013-07-26 PT PT138234851T patent/PT2877184T/pt unknown
-
2015
- 2015-01-25 IL IL236920A patent/IL236920B/en active IP Right Grant
- 2015-01-26 ZA ZA2015/00561A patent/ZA201500561B/en unknown
- 2015-12-03 HK HK15111942.9A patent/HK1210968A1/xx unknown
-
2016
- 2016-12-15 US US15/380,741 patent/US9925201B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HK1210968A1 (en) | 2016-05-13 |
| US9925201B2 (en) | 2018-03-27 |
| NZ704247A (en) | 2018-04-27 |
| MX362185B (es) | 2019-01-08 |
| DK2877184T3 (da) | 2019-12-09 |
| JP2015524434A (ja) | 2015-08-24 |
| CA2880027C (en) | 2021-12-07 |
| IL236920B (en) | 2018-06-28 |
| KR102097663B1 (ko) | 2020-04-06 |
| CN104661663A (zh) | 2015-05-27 |
| US20170189413A1 (en) | 2017-07-06 |
| ES2759781T3 (es) | 2020-05-12 |
| IN2015DN00542A (pt) | 2015-06-26 |
| MX2015001250A (es) | 2015-10-22 |
| ZA201500561B (en) | 2016-04-28 |
| CN107595857A (zh) | 2018-01-19 |
| EP2877184A4 (en) | 2016-03-30 |
| HUE046963T2 (hu) | 2020-04-28 |
| CA2880027A1 (en) | 2014-01-30 |
| WO2014018856A1 (en) | 2014-01-30 |
| PL2877184T3 (pl) | 2020-04-30 |
| KR20150038311A (ko) | 2015-04-08 |
| PT2877184T (pt) | 2019-12-02 |
| JP6209777B2 (ja) | 2017-10-11 |
| EP2877184B1 (en) | 2019-09-04 |
| EP2877184A1 (en) | 2015-06-03 |
| BR112015001847A8 (pt) | 2021-09-08 |
| US20150216877A1 (en) | 2015-08-06 |
| AU2013295645A1 (en) | 2015-02-05 |
| AU2013295645B2 (en) | 2017-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015001847A2 (pt) | composições e tratamento para doenças e distúrbios nos olhos | |
| AU2018236800B2 (en) | DNA-PK inhibitors | |
| BR112015017997A2 (pt) | amidas de quinolina e quinazolina como moduladores de canais de sódio | |
| BR112014026703A2 (pt) | inibidores de dna-pk | |
| EA024842B9 (ru) | Соединения в качестве модуляторов протеинкиназы pi3k | |
| BR112018069533A2 (pt) | tratamento de condições alérgicas oculares com ciclodextrinas | |
| BR112014032699A2 (pt) | métodos de tratamento de síndrome metabólica pediátrica | |
| ECSP14013159A (es) | Compuestos inhibidores de metaloenzimas | |
| BR112015018284A2 (pt) | amidas como moduladores de canais de sódio | |
| BR112015018438A2 (pt) | anticorpo contra c5 e método para prevenir e tratar doenças relacionadas a complemento | |
| UY39413A (es) | Compuestos inhibidores de metaloenzimas | |
| EA201300471A1 (ru) | Замещенные 6-аминоникотинамиды в качестве модуляторов kcnq2/3 | |
| EA201591535A1 (ru) | Замещенные производные 3-фенилпропиламина для лечения офтальмологических заболеваний и расстройств | |
| WO2012080497A3 (en) | Use of lp-pla2 inhibitors in the treatment and prevention of eye diseases | |
| BR112015017775A2 (pt) | enzima cistationina beta-sintase para o tratamento de homocistinúria | |
| BR112014010376A2 (pt) | medicamento para o tratamento de doença do olho anterior que compreende rebamipida e um agente de retenção de lágrima | |
| EA201690039A1 (ru) | Ингибиторы rorc2 и способы их применения | |
| BR112017019971A2 (pt) | exclusão de éxon induzida por anti-sentido em miostatina | |
| MX2013002121A (es) | Quinolina-3-carboxamidas sustituidas como moduladores de kcnq2/3. | |
| GB201213484D0 (en) | Pharmaceutical compositions comprising 15-OHEPA and methods of using the same | |
| PH12016501159A1 (en) | Compositions of omega 3 fatty acids to treat diseases which involve damage to the nervous system | |
| BR112015001859A2 (pt) | tratamento de inflamação utilizando serelaxina | |
| CY1116158T1 (el) | Υποκατεστημενα 2-οξο- και 2-θειοξο-διυδροκινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3 | |
| WO2015048188A3 (en) | Modified fibroblast growth factors for the treatment of ocular disorders | |
| PH12014501573A1 (en) | Topical pharmaceutical compositions comprising bexarotene and a corticosteroids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: GLIA, LLC (US) |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |